Abilify (aripiprazole) is apsychotropic drug(antipsychotic) that alters brain chemical activity used to treat: schizophrenia, mania, depression, bipolar disorders, autistic disorder, and some irritable behavior disorders. GenericAbilify is not available in the U.S., but is available in other countries...
Pharmacological Properties Aripiprazole is a quinolinone derivative with a high affinity for dopamine D 2 and D 3 receptors, and serotonin 5-HT 1a , 5-HT 2A and 5-HT 2B receptors. The mechanism of action of aripiprazole is not yet known, but evidence suggests that its efficacy in the ...
Pharmacological Properties Aripiprazole is a quinolinone derivative with a high affinity for dopamine D 2 and D 3 receptors, and serotonin 5-HT 1a , 5-HT 2A and 5-HT 2B receptors. The mechanism of action of aripiprazole is not yet known, but evidence suggests that its efficacy in the ...
There is no general agreement about specific pharmacological treatment regimens for uncomplicated NMS. If a patient requires antipsychotic drug treatment after recovery from NMS, the potential reintroduction of drug therapy should be carefully considered. The patient should be carefully monitored, since ...
other drugs notessentialto concurrent therapy; 2) intensivesymptomatic treatmentand medical monitoring; and 3) treatment of any concomitant serious medical problems for which specific treatments are available. There is no general agreement about specific pharmacological treatment regimens for uncomplicated NMS...
Pharmacological alleviation and prevention of psychosis is the primary clinical goal. Hyper-active dopamine signalling in the mesolimbic dopaminergic circuit is proposed to contribute to the pathology of schizophrenia [2]. Therefore, antagonists of dopamine D2 and D3 receptors (D2R/D3R) represent a ...
Identifying more effective pharmacological treatments with faster onset of action would be a major advance. Medications thought to modulate the glutamate system are a promising new class of pharmacological agents for the treatment of OCD (3-8). Ketamine, a non-competitive N-methyl-D-aspartate (...
New methodologies for pharmacological treat- ment trials for alcohol dependence. Alcohol Clin Exp Res 20(7 Suppl): 3A–9A. Anton RF, Kranzler H, Breder C, Marcus RN, Carson WH, Han J (2008). A randomized, multicenter, double-blind, placebo- controlled study of the efficacy and safety of...
Due to their dopaminergic action, antipsychotic drugs may be expected to modulate motor function, but the precise effects of these drugs on motor function remain unclear. We carried out a within-subject, double-blind, randomized study of the effects of aripiprazole, haloperidol and placebo on ...
drugs not essential to concurrent therapy; 2) intensive symptomatic treatment and medical monitoring; and 3) treatment of any concomitant serious medical problems for which specific treatments are available. There is no general agreement about specific pharmacological treatment regimens for uncomplicated NMS...